Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 14 OTHER_GOV 2 NIH 2 INDUSTRY 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 17 Rare Diseases 3 Neoplasms 3 Neoplasm Metastasis 3 Leukemia 3 Recurrence 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Genetic Diseases, Inborn 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Squamous Cell 2 Adenocarcinoma Of Esophagus 2 Turcot syndrome 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Respiratory Aspiration 1 Radiation Pneumonitis 1 Prostate Cancer Diagnosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neuroma, Acoustic 1 Neurologic Manifestations 1 Neurofibromatosis 2 1 Neurofibromatoses 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × FED × Turcot syndrome × Clear all

NCT04104893 2026-02-27

CHOMP

VA Office of Research and Development

Phase 2 Active not recruiting

Turcot syndrome, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡